Comments

CervoMed Stock Price, Quotes and Forecasts

Q: What sector and industry does CervoMed (CRVO) operate in?

CervoMed is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

CRVONASDAQ

CervoMed shares are trading higher after Canaccord Genuity raised its price target on the stock from $12 to $21. Several firms also maintained Buy ratings on the stock.

Q4 2024 Earnings were released on Mon Mar 17th, before the market open

CervoMed (CRVO) Forecast

News Earnings CervoMed (CRVO) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

CervoMed Stock Price, Quotes and Forecasts | NASDAQ:CRVO | Benzinga

Explore CervoMed stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for CRVO.

Open	$9.73
Close	-
Volume / Avg.	2.23M / 4.29M
Day Range	$8.78 - $9.93
52 Wk Range	1.80 - 26.38
Market Cap	$79.57M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	92
Short Interest	16.91%
Days to Cover	12.04

Recent News

CervoMed's Dementia Study's 16-Week Data 'Compelling Enough To Move From Sidelines' Analyst Says

CervoMed's Phase 2b study extension shows improved cognitive outcomes with neflamapimod, leading to an analyst upgrade and increased confidence in the drug.

Vandana Singh

This Wells Fargo Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday

Avi Kapoor

Why Paymentus Holdings Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Nov 24

Dec 24

Feb

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$9.73
Close	-
Volume / Avg.	2.23M / 4.29M
Day Range	$8.78 - $9.93
52 Wk Range	1.80 - 26.38
Market Cap	$79.57M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	92
Short Interest	16.91%
Days to Cover	12.04

About CervoMed Inc

Sector

Health Care

Industry

Biotechnology

CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for a...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy CervoMed (CRVO) stock?

You can purchase shares of CervoMed (NASDAQ:CRVO) through any online brokerage.

View our list of the best stock brokerages

Who are CervoMed (CRVO) competitors?

Other companies in CervoMed’s space includes: Skye Bioscience (NASDAQ:SKYE), Inozyme Pharma (NASDAQ:INZY), PepGen (NASDAQ:PEPG), Aligos Therapeutics (NASDAQ:ALGS) and Armata Pharmaceuticals (AMEX:ARMP).

What is the forecast, or price target, for CervoMed (CRVO) stock?

CervoMed has a consensus price target of $24.71.

What is the current price for CervoMed (CRVO)?

The stock price for CervoMed (NASDAQ: CRVO) is $9 last updated March 18, 2025 at 10:05 AM EDT.

Does CervoMed (CRVO) pay a dividend?

There are no upcoming dividends for CervoMed.

When is CervoMed (NASDAQ:CRVO) reporting earnings?

CervoMed’s Q1 earnings are confirmed for Tuesday, May 13, 2025.

Is CervoMed (CRVO) going to split?

There is no upcoming split for CervoMed.

What sector and industry does CervoMed (CRVO) operate in?

CervoMed is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.